Apimeds Share Price
AMEX: APUS | Healthcare$1.86
+$1.86 (--%) Last updated on 19 Nov, 2026 | 02:23 ISTApimeds Stock Performance
Apimeds Share Price Chart
$1.86$2.07
L
H
Apimeds Quarterly Profit & Loss
All figures in USD
Apimeds Annual Profit & Loss
All figures in USD
Apimeds Balance Sheet
All figures in USD Million
Apimeds Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Apimeds
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Apimeds Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.91 | $1.86 | -36.95% |
Oct 2026 | $4.96 | $2.95 | -40.76% |
Sep 2026 | $2.57 | $4.98 | +1.22% |
Aug 2026 | $4.94 | $4.92 | -15.32% |
Jul 2026 | $0.89 | $5.81 | +583.53% |
Jun 2026 | $1.26 | $0.85 | -40.97% |
May 2026 | $5.77 | $1.44 | -15.79% |
Apr 2026 | $1.71 | $1.71 | -1.16% |
Mar 2026 | $1.43 | $1.73 | +37.85% |
Feb 2026 | $1.94 | $1.25 | -33.60% |
Jan 2026 | $1.73 | $1.89 | +2.72% |
Dec 2025 | $3.20 | $1.84 | -35.44% |